1. Home
  2. IMNN vs MMA Comparison

IMNN vs MMA Comparison

Compare IMNN & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • MMA
  • Stock Information
  • Founded
  • IMNN 1982
  • MMA 2013
  • Country
  • IMNN United States
  • MMA Australia
  • Employees
  • IMNN N/A
  • MMA N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • MMA
  • Sector
  • IMNN Health Care
  • MMA
  • Exchange
  • IMNN Nasdaq
  • MMA Nasdaq
  • Market Cap
  • IMNN 12.1M
  • MMA 13.4M
  • IPO Year
  • IMNN 1985
  • MMA 2024
  • Fundamental
  • Price
  • IMNN $0.77
  • MMA $1.25
  • Analyst Decision
  • IMNN Buy
  • MMA
  • Analyst Count
  • IMNN 2
  • MMA 0
  • Target Price
  • IMNN $14.00
  • MMA N/A
  • AVG Volume (30 Days)
  • IMNN 2.3M
  • MMA 434.3K
  • Earning Date
  • IMNN 08-13-2025
  • MMA 01-21-2025
  • Dividend Yield
  • IMNN N/A
  • MMA N/A
  • EPS Growth
  • IMNN N/A
  • MMA N/A
  • EPS
  • IMNN N/A
  • MMA N/A
  • Revenue
  • IMNN N/A
  • MMA $407,412.00
  • Revenue This Year
  • IMNN N/A
  • MMA N/A
  • Revenue Next Year
  • IMNN N/A
  • MMA N/A
  • P/E Ratio
  • IMNN N/A
  • MMA N/A
  • Revenue Growth
  • IMNN N/A
  • MMA N/A
  • 52 Week Low
  • IMNN $0.37
  • MMA $0.60
  • 52 Week High
  • IMNN $3.65
  • MMA $4.11
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 40.86
  • MMA N/A
  • Support Level
  • IMNN $0.70
  • MMA N/A
  • Resistance Level
  • IMNN $0.86
  • MMA N/A
  • Average True Range (ATR)
  • IMNN 0.10
  • MMA 0.00
  • MACD
  • IMNN -0.05
  • MMA 0.00
  • Stochastic Oscillator
  • IMNN 10.34
  • MMA 0.00

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About MMA Alta Global Group Limited

Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.

Share on Social Networks: